Share Price and Basic Stock Data
Last Updated: January 27, 2025, 10:59 pm
PEG Ratio | 0.50 |
---|
Competitors of DRS Dilip Roadlines Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Flomic Global Logistics Ltd | 104 Cr. | 57.2 | 84.0/52.7 | 29.3 | 24.1 | 0.00 % | 8.64 % | 5.18 % | 10.0 |
DJ Mediaprint & Logistics Ltd | 459 Cr. | 113 | 212/42.7 | 63.3 | 11.0 | 0.06 % | 19.0 % | 16.2 % | 10.0 |
Delhivery Ltd | 18,476 Cr. | 248 | 478/244 | 452 | 125 | 0.00 % | 1.73 % | 2.94 % | 1.00 |
Chartered Logistics Ltd | 86.4 Cr. | 8.70 | 14.2/5.87 | 20.3 | 5.27 | 0.00 % | 4.43 % | 0.36 % | 1.00 |
Cargotrans Maritime Ltd | 33.5 Cr. | 82.0 | 103/50.8 | 19.0 | 36.9 | 0.00 % | 18.7 % | 14.0 % | 10.0 |
Industry Average | 4,342.00 Cr | 157.75 | 89.42 | 61.75 | 0.56% | 9.89% | 15.00% | 6.81 |
Quarterly Result
Metric |
---|
Sales |
Expenses |
Operating Profit |
OPM % |
Other Income |
Interest |
Depreciation |
Profit before tax |
Tax % |
Net Profit |
EPS in Rs |
Last Updated: March 3, 2025, 4:42 pm
Below is a detailed analysis of the quarterly data for DRS Dilip Roadlines Ltd based on the most recent figures () and their trends compared to the previous period:
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Mar 2017 | Mar 2022 | Mar 2023 |
---|---|---|---|
Sales | 142 | 191 | 206 |
Expenses | 131 | 181 | 195 |
Operating Profit | 11 | 9 | 11 |
OPM % | 8% | 5% | 5% |
Other Income | 0 | 2 | 1 |
Interest | 3 | 1 | 2 |
Depreciation | 8 | 4 | 5 |
Profit before tax | 0 | 7 | 6 |
Tax % | 306% | 30% | 28% |
Net Profit | 0 | 5 | 4 |
EPS in Rs | 0.44 | 3.07 | 2.77 |
Dividend Payout % | 0% | 0% | 0% |
YoY Net Profit Growth
Year | 2022-2023 |
---|---|
YoY Net Profit Growth (%) | -20.00% |
Change in YoY Net Profit Growth (%) | 0.00% |
DRS Dilip Roadlines Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 1 years from 2022-2023 to 2022-2023.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: Unknown
Month | Mar 2017 | Mar 2022 | Mar 2023 |
---|---|---|---|
Equity Capital | 7 | 15 | 15 |
Reserves | 6 | 37 | 41 |
Borrowings | 47 | 18 | 18 |
Other Liabilities | 34 | 28 | 41 |
Total Liabilities | 94 | 98 | 115 |
Fixed Assets | 54 | 55 | 60 |
CWIP | 0 | 0 | 0 |
Investments | 0 | 1 | 3 |
Other Assets | 40 | 41 | 52 |
Total Assets | 94 | 98 | 115 |
Below is a detailed analysis of the balance sheet data for DRS Dilip Roadlines Ltd based on the most recent figures (Mar 2023) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2023, the value is ₹15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2022) which recorded ₹15.00 Cr..
- For Reserves, as of Mar 2023, the value is ₹41.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹37.00 Cr. (Mar 2022) to ₹41.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Mar 2023, the value is ₹18.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2022) which recorded ₹18.00 Cr..
- For Other Liabilities, as of Mar 2023, the value is ₹41.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹28.00 Cr. (Mar 2022) to ₹41.00 Cr., marking an increase of 13.00 Cr..
- For Total Liabilities, as of Mar 2023, the value is ₹115.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹98.00 Cr. (Mar 2022) to ₹115.00 Cr., marking an increase of 17.00 Cr..
- For Fixed Assets, as of Mar 2023, the value is ₹60.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹55.00 Cr. (Mar 2022) to ₹60.00 Cr., marking an increase of 5.00 Cr..
- For CWIP, as of Mar 2023, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2022) which recorded ₹0.00 Cr..
- For Investments, as of Mar 2023, the value is ₹3.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1.00 Cr. (Mar 2022) to ₹3.00 Cr., marking an increase of 2.00 Cr..
- For Other Assets, as of Mar 2023, the value is ₹52.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹41.00 Cr. (Mar 2022) to ₹52.00 Cr., marking an increase of 11.00 Cr..
- For Total Assets, as of Mar 2023, the value is ₹115.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹98.00 Cr. (Mar 2022) to ₹115.00 Cr., marking an increase of 17.00 Cr..
Notably, the Reserves (₹41.00 Cr.) exceed the Borrowings (18.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Mar 2017 | Mar 2022 | Mar 2023 |
---|---|---|---|
Free Cash Flow
Month | Mar 2017 | Mar 2022 | Mar 2023 |
---|---|---|---|
Free Cash Flow | -36.00 | -9.00 | -7.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2017 | Mar 2022 | Mar 2023 |
---|---|---|---|
Debtor Days | 50 | 20 | 27 |
Inventory Days | |||
Days Payable | |||
Cash Conversion Cycle | 50 | 20 | 27 |
Working Capital Days | -29 | -10 | -13 |
ROCE % | 10% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 23 | Mar 22 | Mar 17 |
---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 2.78 | 3.08 | 0.46 |
Diluted EPS (Rs.) | 2.78 | 3.08 | 0.46 |
Cash EPS (Rs.) | 5.88 | 5.46 | 11.26 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 37.33 | 34.55 | 18.95 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 37.33 | 34.55 | 18.95 |
Revenue From Operations / Share (Rs.) | 136.49 | 126.74 | 202.13 |
PBDIT / Share (Rs.) | 7.95 | 7.62 | 15.77 |
PBIT / Share (Rs.) | 4.85 | 5.24 | 4.95 |
PBT / Share (Rs.) | 3.84 | 4.39 | 0.24 |
Net Profit / Share (Rs.) | 2.78 | 3.08 | 0.43 |
NP After MI And SOA / Share (Rs.) | 2.78 | 3.08 | 0.43 |
PBDIT Margin (%) | 5.82 | 6.01 | 7.80 |
PBIT Margin (%) | 3.55 | 4.13 | 2.44 |
PBT Margin (%) | 2.81 | 3.46 | 0.12 |
Net Profit Margin (%) | 2.03 | 2.42 | 0.21 |
NP After MI And SOA Margin (%) | 2.03 | 2.42 | 0.21 |
Return on Networth / Equity (%) | 7.45 | 8.90 | 2.31 |
Return on Capital Employeed (%) | 10.46 | 12.07 | 8.09 |
Return On Assets (%) | 3.63 | 4.74 | 0.32 |
Long Term Debt / Equity (X) | 0.19 | 0.20 | 2.17 |
Total Debt / Equity (X) | 0.32 | 0.34 | 3.32 |
Asset Turnover Ratio (%) | 1.93 | 0.00 | 0.00 |
Current Ratio (X) | 0.79 | 0.95 | 0.52 |
Quick Ratio (X) | 0.78 | 0.94 | 0.51 |
Interest Coverage Ratio (X) | 7.88 | 8.99 | 3.35 |
Interest Coverage Ratio (Post Tax) (X) | 3.76 | 4.63 | 0.88 |
Enterprise Value (Cr.) | 148.30 | 122.11 | 0.00 |
EV / Net Operating Revenue (X) | 0.72 | 0.63 | 0.00 |
EV / EBITDA (X) | 12.39 | 10.63 | 0.00 |
MarketCap / Net Operating Revenue (X) | 0.65 | 0.59 | 0.00 |
Price / BV (X) | 2.41 | 2.17 | 0.00 |
Price / Net Operating Revenue (X) | 0.65 | 0.59 | 0.00 |
EarningsYield | 0.03 | 0.04 | 0.00 |
After reviewing the key financial ratios for DRS Dilip Roadlines Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 23, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 22) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 23, the value is 2.78. This value is below the healthy minimum of 5. It has decreased from 3.08 (Mar 22) to 2.78, marking a decrease of 0.30.
- For Diluted EPS (Rs.), as of Mar 23, the value is 2.78. This value is below the healthy minimum of 5. It has decreased from 3.08 (Mar 22) to 2.78, marking a decrease of 0.30.
- For Cash EPS (Rs.), as of Mar 23, the value is 5.88. This value is within the healthy range. It has increased from 5.46 (Mar 22) to 5.88, marking an increase of 0.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 37.33. It has increased from 34.55 (Mar 22) to 37.33, marking an increase of 2.78.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 23, the value is 37.33. It has increased from 34.55 (Mar 22) to 37.33, marking an increase of 2.78.
- For Revenue From Operations / Share (Rs.), as of Mar 23, the value is 136.49. It has increased from 126.74 (Mar 22) to 136.49, marking an increase of 9.75.
- For PBDIT / Share (Rs.), as of Mar 23, the value is 7.95. This value is within the healthy range. It has increased from 7.62 (Mar 22) to 7.95, marking an increase of 0.33.
- For PBIT / Share (Rs.), as of Mar 23, the value is 4.85. This value is within the healthy range. It has decreased from 5.24 (Mar 22) to 4.85, marking a decrease of 0.39.
- For PBT / Share (Rs.), as of Mar 23, the value is 3.84. This value is within the healthy range. It has decreased from 4.39 (Mar 22) to 3.84, marking a decrease of 0.55.
- For Net Profit / Share (Rs.), as of Mar 23, the value is 2.78. This value is within the healthy range. It has decreased from 3.08 (Mar 22) to 2.78, marking a decrease of 0.30.
- For NP After MI And SOA / Share (Rs.), as of Mar 23, the value is 2.78. This value is within the healthy range. It has decreased from 3.08 (Mar 22) to 2.78, marking a decrease of 0.30.
- For PBDIT Margin (%), as of Mar 23, the value is 5.82. This value is below the healthy minimum of 10. It has decreased from 6.01 (Mar 22) to 5.82, marking a decrease of 0.19.
- For PBIT Margin (%), as of Mar 23, the value is 3.55. This value is below the healthy minimum of 10. It has decreased from 4.13 (Mar 22) to 3.55, marking a decrease of 0.58.
- For PBT Margin (%), as of Mar 23, the value is 2.81. This value is below the healthy minimum of 10. It has decreased from 3.46 (Mar 22) to 2.81, marking a decrease of 0.65.
- For Net Profit Margin (%), as of Mar 23, the value is 2.03. This value is below the healthy minimum of 5. It has decreased from 2.42 (Mar 22) to 2.03, marking a decrease of 0.39.
- For NP After MI And SOA Margin (%), as of Mar 23, the value is 2.03. This value is below the healthy minimum of 8. It has decreased from 2.42 (Mar 22) to 2.03, marking a decrease of 0.39.
- For Return on Networth / Equity (%), as of Mar 23, the value is 7.45. This value is below the healthy minimum of 15. It has decreased from 8.90 (Mar 22) to 7.45, marking a decrease of 1.45.
- For Return on Capital Employeed (%), as of Mar 23, the value is 10.46. This value is within the healthy range. It has decreased from 12.07 (Mar 22) to 10.46, marking a decrease of 1.61.
- For Return On Assets (%), as of Mar 23, the value is 3.63. This value is below the healthy minimum of 5. It has decreased from 4.74 (Mar 22) to 3.63, marking a decrease of 1.11.
- For Long Term Debt / Equity (X), as of Mar 23, the value is 0.19. This value is below the healthy minimum of 0.2. It has decreased from 0.20 (Mar 22) to 0.19, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 23, the value is 0.32. This value is within the healthy range. It has decreased from 0.34 (Mar 22) to 0.32, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 23, the value is 1.93. It has increased from 0.00 (Mar 22) to 1.93, marking an increase of 1.93.
- For Current Ratio (X), as of Mar 23, the value is 0.79. This value is below the healthy minimum of 1.5. It has decreased from 0.95 (Mar 22) to 0.79, marking a decrease of 0.16.
- For Quick Ratio (X), as of Mar 23, the value is 0.78. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 22) to 0.78, marking a decrease of 0.16.
- For Interest Coverage Ratio (X), as of Mar 23, the value is 7.88. This value is within the healthy range. It has decreased from 8.99 (Mar 22) to 7.88, marking a decrease of 1.11.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 23, the value is 3.76. This value is within the healthy range. It has decreased from 4.63 (Mar 22) to 3.76, marking a decrease of 0.87.
- For Enterprise Value (Cr.), as of Mar 23, the value is 148.30. It has increased from 122.11 (Mar 22) to 148.30, marking an increase of 26.19.
- For EV / Net Operating Revenue (X), as of Mar 23, the value is 0.72. This value is below the healthy minimum of 1. It has increased from 0.63 (Mar 22) to 0.72, marking an increase of 0.09.
- For EV / EBITDA (X), as of Mar 23, the value is 12.39. This value is within the healthy range. It has increased from 10.63 (Mar 22) to 12.39, marking an increase of 1.76.
- For MarketCap / Net Operating Revenue (X), as of Mar 23, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 22) to 0.65, marking an increase of 0.06.
- For Price / BV (X), as of Mar 23, the value is 2.41. This value is within the healthy range. It has increased from 2.17 (Mar 22) to 2.41, marking an increase of 0.24.
- For Price / Net Operating Revenue (X), as of Mar 23, the value is 0.65. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 22) to 0.65, marking an increase of 0.06.
- For EarningsYield, as of Mar 23, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 22) to 0.03, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in DRS Dilip Roadlines Ltd:
- Net Profit Margin: 2.03%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.46% (Industry Average ROCE: 9.89%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 7.45% (Industry Average ROE: 15%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.76
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.78
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 42.7 (Industry average Stock P/E: 89.42)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.32
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.03%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Logistics - Warehousing/Supply Chain/Others | No. 306, 3rd Floor, Secunderabad Telangana 500003 | info@drsindia.in http://www.drsindia.in |
Management | |
---|---|
Name | Position Held |
Mr. Anjani Kumar Agarwal | Managing Director & CEO |
Mr. Sugan Chand Sharma | Whole Time Director |
Mrs. Shamantha Dodla | Non Executive Director |
Mr. Jonnada Vaghira Kumari | Ind. Non-Executive Director |
Mr. Sridharan Chakrapani | Ind. Non-Executive Director |
FAQ
What is the latest intrinsic value of DRS Dilip Roadlines Ltd?
The latest intrinsic value of DRS Dilip Roadlines Ltd as on 08 February 2025 is ₹100.32, which is 15.70% lower than the current market price of ₹119.00, indicating the stock is overvalued by 15.70%. The stock has a market capitalization of 179 Cr. and recorded a high/low of 161/75.4 during the current fiscal year 2024-2025. As of Mar 2023, the company has reserves of ₹41 Cr and total liabilities of 115 Cr.
What is the Market Cap of DRS Dilip Roadlines Ltd?
The Market Cap of DRS Dilip Roadlines Ltd is 179 Cr..
What is the current Stock Price of DRS Dilip Roadlines Ltd as on 08 February 2025?
The current stock price of DRS Dilip Roadlines Ltd as on 08 February 2025 is 119.
What is the High / Low of DRS Dilip Roadlines Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of DRS Dilip Roadlines Ltd stocks is 161/75.4.
What is the Stock P/E of DRS Dilip Roadlines Ltd?
The Stock P/E of DRS Dilip Roadlines Ltd is 42.7.
What is the Book Value of DRS Dilip Roadlines Ltd?
The Book Value of DRS Dilip Roadlines Ltd is 37.2.
What is the Dividend Yield of DRS Dilip Roadlines Ltd?
The Dividend Yield of DRS Dilip Roadlines Ltd is 0.00 %.
What is the ROCE of DRS Dilip Roadlines Ltd?
The ROCE of DRS Dilip Roadlines Ltd is 10.1 %.
What is the ROE of DRS Dilip Roadlines Ltd?
The ROE of DRS Dilip Roadlines Ltd is 7.74 %.
What is the Face Value of DRS Dilip Roadlines Ltd?
The Face Value of DRS Dilip Roadlines Ltd is 10.0.